Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women

被引：61

作者：

Koh, KK

Horne, MK

Cannon, RO

机构：

[1] NHLBI, Cardiol Branch, NIH, Bethesda, MD 20892 USA

[2] NIH, Dept Clin Pathol, Hematol Sect, Bethesda, MD 20892 USA

[3] Gachon Med Coll, Ctr Heart, Dept Internal Med, Inchon, South Korea

来源：

THROMBOSIS AND HAEMOSTASIS | 1999年 / 82卷 / 02期

关键词：

D O I：

10.1055/s-0037-1615889

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：626 / 633

页数：8

共 58 条

[1] Chemoprevention of mammary carcinogenesis in the rat: Combined use of raloxifene and 9-cis-retinoic acid [J].

Anzano, MA ;

Peer, CW ;

Smith, JM ;

Mullen, LT ;

Shrader, MW ;

Logsdon, DL ;

Driver, CL ;

Brown, CC ;

Roberts, AB ;

Sporn, MB .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (02) :123-125

[2]

BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P475

[3] TURNOVER OF HUMAN-TISSUE PLASMINOGEN-ACTIVATOR (TPA) IN RABBITS [J].

BEEBE, DP ;

ARONSON, DL .

THROMBOSIS RESEARCH, 1986, 43 (06) :663-674

[4] MENOPAUSE-RELATED CHANGES IN LIPOPROTEINS AND SOME OTHER CARDIOVASCULAR RISK-FACTORS [J].

BONITHONKOPP, C ;

SCARABIN, PY ;

DARNE, B ;

MALMEJAC, A ;

GUIZE, L .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1990, 19 (01) :42-48

[5] LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN ALPHA-2-MACROGLOBULIN RECEPTOR IS AN HEPATIC RECEPTOR FOR TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].

BU, GJ ;

WILLIAMS, S ;

STRICKLAND, DK ;

SCHWARTZ, AL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7427-7431

[6]

CAINE YG, 1992, THROMB HAEMOSTASIS, V68, P392

[7]

CHANDLER WL, 1990, BLOOD, V76, P930

[8]

*COR DRUG PROJ RES, 1970, JAMA-J AM MED ASSOC, V214, P13036

[9] INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY [J].

CORTELLARO, M ;

COFRANCESCO, E ;

BOSCHETTI, C ;

MUSSONI, L ;

DONATI, MB ;

CARDILLO, M ;

CATALANO, M ;

GABRIELLI, L ;

LOMBARDI, B ;

SPECCHIA, G ;

TAVAZZI, L ;

TREMOLI, E ;

POZZOLI, E ;

TURRI, M ;

CORTELLARO, M ;

COFRANCESCO, E ;

BOSCHETTI, C ;

CARDILLO, M ;

TORRI, M ;

RAINISIO, M ;

GENTILE, G ;

MOREO, G ;

BIANCHI, O ;

LEONARDI, P ;

COLOMBI, M ;

CATALANO, M ;

GALIMBERTI, P ;

RUSSO, U ;

CRESSOTTI, A ;

CARZANIGA, G ;

NOBILI, S ;

NINNO, D ;

DONATI, MB ;

IACOVIELLO, L ;

DEGAETANO, G ;

GABRIELLI, L ;

MARTELLI, E ;

CORSI, G ;

LORENZI, G ;

LOMBARDI, B ;

CARRIERO, MR ;

COLOMBO, R ;

SPECCHIA, G ;

CIOFFI, P ;

SCIRE, A ;

TAVAZZI, L ;

GIANNUZZI, P ;

CORRA, U ;

TEMPORELLI, L ;

MORA, F .

ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10) :1412-1417

[10] Risk of venous thromboembolism in users of hormone replacement therapy [J].

Daly, E ;

Vessey, MP ;

Hawkins, MN ;

Carson, JL ;

Gough, P ;

Marsh, S .

LANCET, 1996, 348 (9033) :977-980

← 1 2 3 4 5 6 →